Literature DB >> 370159

Postmarketing surveillance of new drugs: I. Review of objectives and methodology.

W M Wardell, M C Tsianco, S N Anavekar, H T Davis.   

Abstract

Mesh：

Year:  1979        PMID： 370159     DOI： 10.1002/j.1552-4604.1979.tb02464.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  8 in total

1.  A survey of adverse drug reactions in family practice.

Authors:  J L Reynolds
Journal:  Can Fam Physician       Date:  1984-01       Impact factor: 3.275

2.  Monitoring adverse drug reactions: a preliminary study.

Authors:  J L Reynolds
Journal:  Can Fam Physician       Date:  1981-08       Impact factor: 3.275

3.  New approaches to postmarketing surveillance.

Authors:  S Fisher; S G Bryant; R M Kluge
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  The role of record linkage in post-marketing drug surveillance.

Authors:  I K Crombie
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

5.  Assessment of adverse drug reactions in psychiatric hospitals.

Authors:  R Grohmann; H Hippius; B Müller-Oerlinghausen; E Rüther; J Scherer; L G Schmidt; A Strauss; B Wolf
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  [Drug safety: activities of the manufacturer].

Authors:  P Krupp
Journal:  Soz Praventivmed       Date:  1980-03

Review 7.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

Review 8.  Pharmacovigilance: methods, recent developments and future perspectives.

Authors:  L Härmark; A C van Grootheest
Journal:  Eur J Clin Pharmacol       Date:  2008-06-04       Impact factor: 2.953
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.